Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic.

IF 4.3 2区 医学 Q1 INFECTIOUS DISEASES Antibiotics-Basel Pub Date : 2024-10-13 DOI:10.3390/antibiotics13100966
Andreea-Loredana Golli, Simona Georgiana Popa, Monica Laura Cara, George-Alin Stoica, Dragos Fortofoiu, Maria Stoica
{"title":"Antibiotic Resistance Pattern of Pathogens Isolated from Pediatric Patients during and after the COVID-19 Pandemic.","authors":"Andreea-Loredana Golli, Simona Georgiana Popa, Monica Laura Cara, George-Alin Stoica, Dragos Fortofoiu, Maria Stoica","doi":"10.3390/antibiotics13100966","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background/Objectives</b>: The present study aims to highlight the possible significant changes due to the COVID-19 pandemic in the resistance of pathogens involved in cases of pediatric infections. <b>Methods</b>: This study included children hospitalized in the Pediatric Intensive Care Unit, Surgery and Pediatrics from a tertiary teaching hospital, during and after the COVID-19 period (2020-2023). <b>Results</b>: The research included 845 samples collected during 2020-2023, from 685 pediatric patients. A total of 937 bacterial isolates were obtained, of which 509 isolates (54.32%) were Gram-negative bacteria. Around 30% of all the pathogens were multidrug-resistant (MDR), with a statistically significant increase post-pandemic, in the case of the MDR <i>Escherichia coli</i> strains (<i>p</i> < 0.05). A very high percentage of MDR <i>Acinetobacter</i> spp. isolates was found, with an important, but not statistically significant, increase in the post-pandemic period. The highest percentage of the MDR Gram-positive pathogens was registered in the case of <i>S. aureus</i> strains (31.80%). Over 20% of the <i>Coagulase-negative Staphylococci (CoNS)</i> strains isolated between 2020 and 2023 were MDR, with an important increase in the post-COVID-19 period. The proportion of carbapenem-resistant Gram-negative pathogens significantly decreased in the post-COVID-19 period compared with the COVID-19 period (<i>p</i> < 0.05), especially in the case of the <i>Klebsiella</i> spp. strains. <b>Conclusions</b>: Our findings revealed the increase in the post-COVID-19 period of the prevalence of MDR strains of <i>Acinetobacter</i> spp., <i>CoNS</i>, and <i>Escherichia coli</i> isolated in pediatric patient samples and a significant decline in the trend of the carbapenem-resistant Gram-negative pathogens, which may be due to the testing rate and to the specific pathology of the pediatric patients hospitalized in the two periods.</p>","PeriodicalId":54246,"journal":{"name":"Antibiotics-Basel","volume":"13 10","pages":""},"PeriodicalIF":4.3000,"publicationDate":"2024-10-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11505055/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antibiotics-Basel","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/antibiotics13100966","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background/Objectives: The present study aims to highlight the possible significant changes due to the COVID-19 pandemic in the resistance of pathogens involved in cases of pediatric infections. Methods: This study included children hospitalized in the Pediatric Intensive Care Unit, Surgery and Pediatrics from a tertiary teaching hospital, during and after the COVID-19 period (2020-2023). Results: The research included 845 samples collected during 2020-2023, from 685 pediatric patients. A total of 937 bacterial isolates were obtained, of which 509 isolates (54.32%) were Gram-negative bacteria. Around 30% of all the pathogens were multidrug-resistant (MDR), with a statistically significant increase post-pandemic, in the case of the MDR Escherichia coli strains (p < 0.05). A very high percentage of MDR Acinetobacter spp. isolates was found, with an important, but not statistically significant, increase in the post-pandemic period. The highest percentage of the MDR Gram-positive pathogens was registered in the case of S. aureus strains (31.80%). Over 20% of the Coagulase-negative Staphylococci (CoNS) strains isolated between 2020 and 2023 were MDR, with an important increase in the post-COVID-19 period. The proportion of carbapenem-resistant Gram-negative pathogens significantly decreased in the post-COVID-19 period compared with the COVID-19 period (p < 0.05), especially in the case of the Klebsiella spp. strains. Conclusions: Our findings revealed the increase in the post-COVID-19 period of the prevalence of MDR strains of Acinetobacter spp., CoNS, and Escherichia coli isolated in pediatric patient samples and a significant decline in the trend of the carbapenem-resistant Gram-negative pathogens, which may be due to the testing rate and to the specific pathology of the pediatric patients hospitalized in the two periods.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19 大流行期间和之后从儿科患者中分离出的病原体的抗生素耐药性模式。
背景/目的:本研究旨在强调 COVID-19 大流行可能导致儿科感染病例中病原体的耐药性发生重大变化。研究方法:本研究包括在 COVID-19 期间(2020-2023 年)和之后在一家三级教学医院的儿科重症监护室、外科和儿科住院的儿童。研究结果研究包括在 2020-2023 年期间从 685 名儿科患者中采集的 845 份样本。共分离出 937 株细菌,其中 509 株(54.32%)为革兰氏阴性菌。在所有病原体中,约 30% 的病原体具有多重耐药性 (MDR),其中大肠埃希菌的多重耐药性菌株在大流行后有显著增加(p < 0.05)。发现耐 MDR 的醋氨梭菌属分离株的比例非常高,在大流行后有显著增加,但无统计学意义。革兰氏阳性病原体中耐药菌株比例最高的是金黄色葡萄球菌(31.80%)。在 2020 年至 2023 年期间分离到的凝固酶阴性葡萄球菌(CoNS)菌株中,超过 20% 为 MDR,在后 COVID-19 期间显著增加。与 COVID-19 期间相比,COVID-19 后期间耐碳青霉烯类革兰氏阴性病原体的比例显著下降(p < 0.05),尤其是克雷伯氏菌属菌株。结论我们的研究结果表明,在后 COVID-19 时期,儿科患者样本中分离出的对 MDR 菌株耐药的醋杆菌属、CoNS 和大肠埃希菌的流行率有所上升,而对碳青霉烯类耐药的革兰氏阴性病原体的流行率则呈显著下降趋势,这可能与检测率以及两个时期住院的儿科患者的具体病理情况有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Antibiotics-Basel
Antibiotics-Basel Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
7.30
自引率
14.60%
发文量
1547
审稿时长
11 weeks
期刊介绍: Antibiotics (ISSN 2079-6382) is an open access, peer reviewed journal on all aspects of antibiotics. Antibiotics is a multi-disciplinary journal encompassing the general fields of biochemistry, chemistry, genetics, microbiology and pharmacology. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Therefore, there is no restriction on the length of papers.
期刊最新文献
The Synergy of Machine Learning and Epidemiology in Addressing Carbapenem Resistance: A Comprehensive Review. Resilience of Loin Meat Microbiota and of Resistance Genes to a Chlortetracycline Treatment in Weaned Piglets. Gut Microbiota and New Microbiome-Targeted Drugs for Clostridioides difficile Infections. Combinations of Terminalia bellirica (Gaertn.) Roxb. and Terminalia chebula Retz. Extracts with Selected Antibiotics Against Antibiotic-Resistant Bacteria: Bioactivity and Phytochemistry. Isatin Bis-Imidathiazole Hybrids Identified as FtsZ Inhibitors with On-Target Activity Against Staphylococcus aureus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1